Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 347
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Reader Login
Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2016| October-December  | Volume 5 | Issue 4  
    Online since October 18, 2016

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness
Raziyeh Kheshti, Mohammadsadegh Aalipour, Soha Namazi
October-December 2016, 5(4):257-263
DOI:10.4103/2279-042X.192461  PMID:27843962
  62 5,296 966
Comparative evaluation between two methods of induced hypotension with infusion of Remifentanil and Labetalol during sinus endoscopy
Parvin Sajedi, Ali Rahimian, Gholamreza Khalili
October-December 2016, 5(4):264-271
DOI:10.4103/2279-042X.192463  PMID:27843963
  11 3,118 328
Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
Mohammadreza Seyyedmajidi, Anahita Ahmadi, Shahin Hajiebrahimi, Seyedali Seyedmajidi, Majid Rajabikashani, Mona Firoozabadi, Jamshid Vafaeimanesh
October-December 2016, 5(4):248-251
DOI:10.4103/2279-042X.192462  PMID:27843960
  10 5,286 502
Gemcitabine and Cisplatin induced posterior reversible encephalopathy syndrome: A case report with review of literature
Rohit Santosh Kabre, Krishna Marotirao Kamble
October-December 2016, 5(4):297-300
DOI:10.4103/2279-042X.192464  PMID:27843969
  7 2,348 280
Detecting and managing drug-related problems in the neurology ward of a tertiary care teaching hospital in Iran: A clinical pharmacist's intervention
Farzaneh Foroughinia, Seyyed Ramtin Tazarehie, Peyman Petramfar
October-December 2016, 5(4):285-289
DOI:10.4103/2279-042X.192455  PMID:27843966
  6 2,784 323
Exploring clinical pharmacists' perception of their impact on healthcare in Khartoum State, Sudan
Anas Mustafa Ahmed Salim, Arwa Hassan Ahmed Elhada, Bashir Elgizoli
October-December 2016, 5(4):272-278
DOI:10.4103/2279-042X.192459  PMID:27843964
  6 2,764 277
Does Omega-3 supplementation decrease carotid intima-media thickening in hemodialysis patients?
Mohammad Hossein Kajbaf, Fariborz Khorvash, Mojgan Mortazavi, Shahrzad Shahidi, Firoozeh Moeinzadeh, Ziba Farajzadegan, Shahnaz Amani Tirani
October-December 2016, 5(4):252-256
DOI:10.4103/2279-042X.192451  PMID:27843961
  5 3,036 302
Antimicrobial resistance pattern of Gram-positive bacteria during three consecutive years at the nephrology ward of a tertiary referral hospital in Shiraz, Southwest Iran
Iman Karimzadeh, Mona Mirzaee, Niloofar Sadeghimanesh, Mohammad Mahdi Sagheb
October-December 2016, 5(4):238-247
DOI:10.4103/2279-042X.192460  PMID:27843959
  5 3,095 407
Moxifloxacin-induced acute psychosis: A case report with literature review
Faizan Mazhar, Shahzad Akram, Nafis Haider
October-December 2016, 5(4):294-296
DOI:10.4103/2279-042X.192457  PMID:27843968
  4 2,938 338
Prevalence of pulmonary edema among the deceased cases with acute Methadone poisoning: A report from Iran
Nastaran Eizadi-Mood, Seyed Amir Hossein Madani Naeini, Mahrang Hedaiaty, Ali Mohammad Sabzghabaee, Maryam Moudi
October-December 2016, 5(4):290-293
DOI:10.4103/2279-042X.192454  PMID:27843967
  3 2,507 251
A new approach to Vancomycin utilization evaluation: A cross-sectional study in intensive care unit
Atefeh Mahmoodian, Saeed Abbasi, Shadi Farsaei
October-December 2016, 5(4):279-284
DOI:10.4103/2279-042X.192453  PMID:27843965
  3 2,785 319
Ascorbic acid in septic shock
Hossein Khalili
October-December 2016, 5(4):301-302
DOI:10.4103/2279-042X.192452  PMID:27843970
  1 2,279 323
Evaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study
Marzieh Zargaran, Shekoufeh Nikfar, Abdol Majid Cheraghali
October-December 2016, 5(4):234-237
DOI:10.4103/2279-042X.192456  PMID:27843958
  1 2,797 350
Whether HER2-positive non-breast cancers are candidates for treatment with Ado-trastuzumab emtansine?
Azadeh Moghaddas, Ali Borhani
October-December 2016, 5(4):227-233
DOI:10.4103/2279-042X.192458  PMID:27843957
  - 3,350 638